首页> 外文OA文献 >676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)

【2h】

676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)

机译：676.通过12项医疗结果测量的健康有关的生活质量（HRQOL），其中12项医学结果测量的成人中的短型（SF-12）与接受Lefamulin（Lef）或Moxifloxacin（ MOX）在两相3随机，双盲，双伪临床试验（LEAP 1和2）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Thomas Lodise; Sam Colman; Elizabeth Alexander; Daniel Stein; David Fitts; Lisa Goldberg; Jennifer Schranz;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials [J] . Thomas P Lodise, Sam Colman, Elizabeth Alexander, Open Forum Infectious Diseases . 2020 ,第6期

机译：通过12项短型调查的健康有关的生活质量，其成年人在2阶段III中接受了甲伐素或宫霉素的成人患者，在2阶段III随机，双盲，双伪临床试验
2. Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials [J] . Thomas Lodise, Sam Colman, Daniel S Stein, Open Forum Infectious Diseases . 2020 ,第5期

机译：hoc评估时间与社区收购的细菌肺炎住院的成年人的临床反应的时间评估，他们在2期III中接受了甲伐素或宫蛋白酰辛，双盲，双伪临床试验
3. Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial [J] . Alexander Elizabeth, Goldberg Lisa, Das Anita F., JAMA: the Journal of the American Medical Association . 2019 ,第17期

机译：口服甲伐素对艾灸氧氟沙星进行社区收养的细菌肺炎的成人早期临床反应：Leap 2随机临床试验
4. 676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized Double-Blind Double-Dummy Clinical Trials (LEAP 1 and 2) [O] . Thomas Lodise, Sam Colman, Elizabeth Alexander, -1

机译：676.通过接受Lefamulin（LEF）或Moxifloxacin（LEFA）或Moxifloxacin（莫西沙星）（ MOX）在两个3期随机双盲双虚拟临床试验中进行（LEAP 1和2）
5. 717. Lefamulin (LEF) vs. Moxifloxacin (MOX) in Patients With Community-Acquired Bacterial Pneumonia (CABP) at Risk for Poor Efficacy or Safety Outcomes: Pooled Subgroup Analyses From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Noninferiority Clinical Trials [O] . Jennifer Schranz, Lisa Goldberg, Anita F Das, 2019

机译：717.在患有效力或安全结果的危险中，患有患有患者的患者患者的Lefamulin（Lef）与莫西林（Mox）患者（CABP）患有较差的疗效或安全结果：汇集亚甘霖对肺炎（LEAP）1和Leap 2阶段3的群体分析非流动性临床试验

著录项

相似文献

相关主题

期刊订阅